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Abstract
Objective: To compare the clinical outcomes of laparoscopic transient uterine artery
ligation plus myomectomy (LTUAL) to simple laparoscopic myomectomy (LM) for
symptomatic myomas.
Methods: A comparative observational study was adopted; 167 patients with a
diagnosis of symptomatic uterine myoma were retrospectively observed. And 84
patients underwent LTUAL and LM, 83 patients underwent LM only. Operative time,
blood loss, gonadal hormone level, uterine artery resistance index, menorrhea,
pregnancy rate, and recurrence rate of myoma were evaluated.
Results: The intraoperative blood loss in the LTUAL group was lower than in the LM
group. The menstrual blood volume (MBV) and the menstrual period of the LTUAO
group were unchanged after operation relative to the prediseased volume. No
significant difference was found in the resistance index of the uterine artery blood
flow, the recurrence rate, and the fertility rate between the LTUAL and the LM groups.
Conclusions: LTUAL and LM are a promising surgical treatment for symptomatic
uterine myoma and did not produce any appreciable adverse effect on fertility.
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1. Introduction
Uterine myomas are the most common benign tumor of the female reproductive system. It is
estimated that they occur in up to 35% of women 35 years of age [1]. Most of these myomas
are asymptomatic, although some may cause symptoms that require a definite treatment.
Approximately 30% of women with myomas have been reported to have menstrual abnor‐
malities, most often menorrhagia. Dysmenorrhea also may occur. Acute pain can occur with
red degeneration, necrosis, and torsion of a pedunculated myoma. Large myomas can also
stimulate urinary tract compression, resulting in symptoms such as urinary frequency and
urgency. Myomas may also cause infertility and miscarriage [2].
There are many therapeutic strategies, but the management of women with symptomatic
uterine myomas depends on the patient’s age, the reasons for treatment, the issue of fertility
preservation, and the patient’s preference. Although hysterectomy has long been considered
a good choice if women have completed childbearing, there are many other therapeutic
approaches available for preservation of the uterus, because psychologically, the uterus has
been regarded as the regulator and controller of important physiologic functions, a sexual
organ, a source of energy and vitality, and a maintainer of youth and attractiveness. Some of
these therapies include uterine artery embolization (UAE), MRgFUS (magnetic resonance-
guided focused ultrasound surgery), and ultrasound-guided ablation (VizAblate™ [Gyne‐
sonics, Redwood City, CA, USA] and Acessa™ [Halt Medical, Inc., Brentwood, CA, USA]
procedures). The standard treatment for symptomatic uterine fibroids has always been
myomectomy. Myomectomy has been traditionally performed by laparotomy, but over the
past decade, laparoscopic and hysteroscopic techniques have been developed. The surgery can
now be performed laparoscopically and hysteroscopically. Laparoscopic surgery has seen
significant improvement in its techniques and instruments, and has been developed and used
in the management of various kinds of benign diseases. Although some concerns about the
role of laparoscopic myomectomy (LM) as a treatment option for symptomatic uterine myomas
are still present, it is still widely used for symptomatic subserosal fibroids and can even be
used for intramural fibroids, depending on the position of the fibroid and the skills of the
surgeon. Many comparison studies have evaluated the safety and feasibility of abdominal
myomectomy and LM [3]. These studies showed that LM is clearly associated with shorter
hospitalization, faster recovery, less expense, less pain, less blood loss, less fever, and fewer
surgical complications compared with abdominal myomectomy. Pregnancy rates and recur‐
rence rates appear to be comparable between LM and abdominal myomectomy [3]. Therefore,
the use of LM can be considered as one of the choices in the management of women with
symptomatic uterine myomas.
Myomectomy is a challenging procedure for gynecologists and can result in excessive blood
loss. In general, it is suitable only for patients who have a few relatively small myomas or
myomas that are primarily below the serosa [4]. The relative contraindications of LM include
a history of multiple, large, intrauterine wall myomas [5]. With recent technique advances, LM
can be performed as the treatment for relatively large uterine fibroids. However, the challenges
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of increased operation time and the high risk of blood loss still remain [6]. Several methods to
control blood loss during LM are available, including the use of dilute vasopressin, hypoten‐
sive anesthesia, and administration of GnRH agonists. Until now, there is no single method to
completely control intraoperative blood loss and prevent postoperative exudation from the
uterine incisional wound.
Recently, a major development in overcoming this problem is the laparoscopic uterine artery
occlusion (LUAO) [7], which was introduced in 2001. This procedure can result in remarkably
decreased blood loss in LM [8], and it has expanded the application of LM greatly, such as the
large, multiple, and deep myomas located in the uterus. However, the possible side effects of
LUAO, such as the increased abortion rate and preterm delivery [9, 10], lack further verification
in literature. As a result, we have developed a new approach to LUAO: laparoscopic transient
uterine artery ligation (LTUAL). In this study, we attempt to elucidate this new approach and
evaluate the possible results of LTUAL and LM on outcomes such as ovary function, recurrence
rates, and fertility compared with traditional LM.
2. Materials and methods
2.1. Patients
A comparative observational study was adopted. Between January 1, 2006, and June 31, 2008,
167 patients with a diagnosis of symptomatic uterine myoma and who were hospitalized at
Southwest Hospital in Chongqing, China, for LM were enrolled in this study.
Per the inclusion criteria, all patients had symptoms attributable to myomas, including
menorrhagia, bulge sensation, pain, and urinary frequency, with the most common being
menorrhagia. The diagnosis was confirmed by ultrasonography or computed tomography
scan. All the patients preferred not to undergo a hysterectomy. The exclusion criteria elimi‐
nated women who were older than 43 years or had an additional gynecologic disease such as
adenomyoma, genital malignant tumor, genital malformation, premature ovarian failure,
polycystic ovary, fallopian tubes adhesion or imperforation, or sactosalpinx. Women whose
husbands had abnormal results of the seminal fluid test were also excluded.
The institutional review board of our institution approved the study, and all participants
provided written informed consent before entry. All patients in this study were thoroughly
notified of the benefits, curative effects, potential risks, and uncertain fertility issues related to
uterine artery occlusion. Eighty-four patients who accepted LTUAL were placed in the LTUAL
group and treated with LTUAL and LM. Eighty-four patients who refused LTUAL were placed
in the LM group and received LM only. There was no difference in the age, the body mass
index, the maximal diameter, and the location and number of myomas between the two groups
(Table 1).
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Characteristic LTUAL (n = 84) LM (n = 83) P value
Age, y 32.5 (25–43) 32 (26–43) 0.936
Body mass index, kg/m2 22.65 (18.1–27.7) 23.1 (18.4–27.1) 0.927
Pregnancy history, n
Nullipara 52 (61.9%) 59 (71.1%)
Multipara 32 (38.1%) 24 (28.9%)
Symptoms, n
Menorrhagia 61 (72.6%) 56 (67.5%) 0.468
Bulge sensation 52 (61.9%) 48 (57.8%) 0.591
Pain 19 (22.6%) 30 (36.1%) 0.055
Urinary frequency 16 (19.0%) 21 (25.3%) 0.331
Myomas
Diameter, cm 5.8 (3–12) 5.9 (3–11) 0.504
Location, n 0.973
Subserous 22 (26.2%) 20 (24.1%)
Intrauterine wall 32 (38.1%) 28 (33.7%)
Submucosal, n 7 (8.3%) 9 (10.8%)
Multiple, n 23 (27.4%) 26 (31.3%)
Average multiple number 4 (2–13) 3.5 (2–8) 0.87
Table 1. Basic characteristics of the enrolled women.
2.2. Operative procedures
All procedures were performed under general endotracheal anesthesia. The LTUAL technique
was performed like the LUAO previously described [7], except that the uterine artery was
transiently ligated by a slipknot with a surgical silk suture. The successful artery ligation could
be confirmed as previously described [8]. Next, the LM progress was performed as previously
described [8]. Last, the slipknot was removed and the uterine arteries were recanalized. Finally,
the fallopian tube perfusion test was performed to exclude patients with broken uterine walls
or obstructed fallopian tubes. Blood loss was estimated by calculating the blood volume of the
suction machine during surgery.
2.3. Follow-up method
The follow-up time ranged 10–40 months. The routine time of interview was 3 and 6 months
and at 1, 2, and 3 years after the operation or at any time if any problems arose. All patients
were advised to engage in contraceptive measures by the use of condoms for 24 months. After
this period, women were free to seek conception.
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2.4. Assessment of menstrual patterns
To evaluate the effect of LTUAL on menorrhea, a questionnaire was sent to each of the patients
when compiling their case history. The number of menstrual pads used by each woman was
recorded during three menstrual cycles: before the diseased state, during the disease, and after
surgery. We set a value of 1 for the menstrual blood volume (MBV) index for the prediseased
period for each patient. The diseased MBV index is equal to the number of menstrual pads
used during the diseased period divided by the number of menstrual pads used before the
diseased period. Once regular menorrhea recovered at least for 6 months following the
operation, the postoperation MBV index was recorded as the diseased MBV index. Because
the MBV during the diseased state was mostly irregularly increased in the presence of myomas
and was inconsequential for the evaluation of the single effect of LTUAL, we decided to
abandon this index. The only comparison was made for the two periods: before the disease
occurred and postoperation.
2.5. Recurrence assessment
All patients received an ultrasound examination 3 months after the operation to confirm the
effectiveness of the procedure and to exclude the patients with residual myomas; they also
received an ultrasound examination at each routine interview. The recurrence was defined
when uterine myomas, with a minimum diameter of 0.5 cm, were found in patients without
residual myomas.
2.6. Statistical analysis
SPSS 11.5 (SPSS, Inc., Chicago, IL) was used for statistical analysis. Data are presented as mean
± SD, number (%), and median (range). The difference in means between the groups was tested
by using an ANOVA test, if the variable under comparison was not normally distributed. The
rank sum test was used. The categorical variables are presented as percentages, and were
compared using χ2 tests or Fisher's exact tests. P<0.05 was considered statistically significant.
3. Results
All  167  patients  underwent  laparoscopic  operations  successfully  without  intraoperative
complications, with no cases converting to laparotomy. In the LM group, one patient experi‐
enced a 4-hour operation and lost 600 ml of blood during surgery, which necessitated a blood
transfusion; later, a wound infection developed, and the patient stayed in the hospital for 21
days for intravenous fluid and antibiotic therapy. Five patients in the LM group received blood
transfusions during or after the operation. Two patients in the LTUAL group and four patients
in the LM group suffered from urinary tract infections. In addition, one patient in the LTUAL
group and four patients in the LM group had a high fever (body temperature > 38.5°C) for more
than 3 days and stayed in the hospital for antibiotic therapy for 1 week. There were no severe
complications such as ureter, bladder, or bowel injury during the perioperative period. All
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pathologic examinations documented the presence of uterine leiomyomas. There was no
statistical difference in the average operation time between the LTUAL and the LM groups
(P=0.41). The transient ligation time in the LTUAL group ranged 55–155 minutes, and the median
time was 98.5 minutes. Blood loss was significantly lower in the LTUAL group than in the LM
group (P<0.01). The mean postoperative hospital stay was 3.8 days (range, 3–21 days).
The results of the menorrhea assessment are given in Table 2. The MBV, menstrual period, and
menstrual cycle were unchanged after surgery in the two groups compared with before the
disease occurred (P>0.05).
LTUAL LM
Volume rank (before disease) 1.00 ± 0.00 1.00 ± 0.00
Volume rank (after surgery) 1.00 ± 0.00 1.00 ± 0.10
P 0.071 0.316
Menstrual period (before disease) 5 ± 1 5 ± 1
Menstrual period (after surgery) 5 ± 1 5 ± 1
P 0.227 0.091
Menstrual cycle (before disease) 28 ± 2 29 ± 3
Menstrual cycle (after surgery) 28.5 ± 2 29 ± 2
P 0.782 0.326
Table 2. Menorrhea evaluation (median ± interquartile range).
The uterine artery resistance index (RI) was also tested. There was no statistical difference
found between the two groups each time, at the preoperative period, and at 3 days, 6 months,
and 12 months after surgery in each group (P>0.05; Table 3).
Period LTUAL (n = 84) LM (n = 83) P value
Before surgery 0.73 (0.48–0.90) 0.71 (0.50–0.88) 0.156
After surgery
3 days 0.705 (0.49–0.87) 0.69 (0.53–0.89) 0.744
6 months 0.69 (0.48–0.89) 0.695 (0.47–0.88) 0.466
12 months 0.69 (0.48–0.87) 0.70 (0.49–0.86) 0.882
Table 3. Comparison of uterine artery resistance index.
Recurrence rates following the different procedures were examined next. There were six cases
confirmed with residual myomas by ultrasonography 3 days after the operations, and these
cases were excluded from those subjected to recurrence follow-up for the interference of the
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recurrence assessment. The data from the remaining the cases were collected and are presented
in Table 4. There was no statistical difference between the LTUAL group and the LM group
(P=0.237).
The fertility evaluation is presented in Table 4. In the LTUAL group, 31 patients were still using
contraception at the 2-year follow-up, and five of the remaining 53 patients have consistently
used contraception 2 years later. In the remaining 48 patients seeking pregnancy, the outcomes
were as follows: one patient had an ectopic pregnancy that was later subjected to treatment by
methotrexate; 15 patients conceived normally, and of these, 9 patients proceeded to full-term
pregnancy. In the LM group, 28 patients were still using contraception at the 2-year follow up;
13 patients were currently still using contraception 2 years later. Among the remaining 42
patients attempting to become pregnant, miscarriage occurred in two patients and 16 patients
had a normal pregnancy (Table 4), half of whom carried a baby to full-term. There was no
statistical difference between the LTUAL and the LM groups (P=0.495).
LTUAL (n = 84) LM (n = 83) P value OR (95% CI)
Operation duration, min 121.92 ± 18.48a 126.33 ± 27.13 0.313 —
Blood loss, mlb 75 (40–190) 170 (100–600) 0.001 —
Recurrence, n 16/82 (19.51%)c 10/79 (12.66%)c 0.237 1.673 (0.708–3.950)
Pregnancy, n 15/48 (31.25%)d 16/42 (38.10%)d 0.495 0.739 (0.309–1.767)
Note: OR = odds ratio; CI = confidence interval.
a Mean ± SD.
b Precise scale = 5 ml.
c Patients with residual myomas were excluded.
d Patients still using contraception were excluded. Total number of women included those who were no longer using
contraception and were seeking pregnancy.
Table 4. Surgical parameters and recurrence, pregnancy follow-up data.
4. Discussion
During LM, failure of hemostasis is the primary factor resulting in conversion to laparotomy
[11]. However, this problem was addressed by the introduction of LUAO: Liu et al. [7] reported
LUAO as a new method for treating symptomatic myomas, but they used this technique as a
primary treatment without proceeding to myomectomy, and the recurrence rate was reported
as 28.4% within the 4-year follow-up period [12]. In our previous study [8], this technique was
used as a supplement for LM first, with the uterine arteries being blocked while the myomas
were completely removed. This technique resulted in a remarkable blood loss in the operation
and a low recurrence rate, but possible side effects in uterine or ovarian function, especially
long-term effects on fertility, need further study.
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Because of the possible side effects of LUAO on fertility [9, 10], we developed LTUAL to be
used in patients who wish to comply after a thorough explanation of the pros and cons of the
procedure. This discussion allowed for the evaluation of the effects of LTUAL on menorrhea,
fertility, and the recurrence rates of myomas.
In this study, LTUAL decreased intraoperative blood loss remarkably compared with LM.
With the critical problem being tackled, we were able to conduct LM for large, multiple,
intrauterine wall and especially submucosal myomas. There was no difference in the duration
of the operation between the two groups, because in our experience, LTUAL can be performed
within 10 minutes by an experienced gynecologist. However, in the LM group, more time is
usually spent trying to maintain the hemostasis of the sutured wounds of the uterine cavity.
A problem related to this study may be the ligation time of the uterine artery. Traditional
uterine tourniquets are usually best used for no more than 1 hour [13] to avoid irreversible
damage to the uterine myometrium and the risk of embolic events. Although a review showed
no embolic phenomena after detorsion in ischemic necrotic twisted adnexa [14], Wang et al.
[15] used average occlusion periods of approximately 2 hours without any complications. Our
experience would suggest that the occlusion period of the uterine arteries is not a considerable
problem because of the intact ovarian and vaginal ascending arteries, which compose part of
the triple-extrinsic uterine blood supply system. At the least, our transient ligation period
(97.93 ± 19.08 minutes) was verified to be harmless to the myometrium and did not induce any
complications.
By the assessment of unchanged uterine RI, menstrual pattern, and the recurrence of myomas,
we thought the LTUAL interfered minimally with ovary function, uterine myometrium, and
the uterus status, which were important for fertility.
Because of deficiencies associated with our laboratory, we had to study ovarian function
indirectly by the indices of uterine artery RI and the menorrhea change. First, the blood supply
of the ovary is the main factor that influences ovarian function. In this type of surgery, the
ovarian vessels were untouched; the only operation that could disturb the ovarian blood
supply was the LTUAL, because the uterine artery is one of the ramus anastomoticus of ovarian
blood supply. We found no differences of the uterine artery RI between the two groups and
between different periods. As a result, we verified that the blood supply in the ovaries was
not disturbed by LTUAL. Second, no differences in menorrhea were found between the
prediseased state and the postoperative state in the LTUAL and LM groups, so we inferred
that LTUAL had minimal interference on ovary function. In our previous study [8] and in the
recent literature [12, 16, 17], the recurrence rate using LUAO was low and markedly lower
than that reported for abdominal myomectomy and LM [18, 19, 20]. The decreased blood
supply to the uterus induced gradual necrosis of the myomas. Lee et al. [21] found a markedly
decreased RI index 4 months after LUAO compared with that before surgery. Other similar
researches [22, 23] found a shrinking of myomas after LUAO and confirmed that apoptosis
was the primary mechanism by which this occurred [23]. In contrast, the recurrence rates
appear to be no different between the LTUAL and the LM groups. Thus, minimal interference
of LTUAL on the uterine artery and uterine status is confirmed by unchanged menorrhea and
recurrence rate of myomas.
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In this study, the gestation rate of patients was evaluated over a 16–36 months follow-up. No
difference was found between the LTUAL and the LM groups on the gestation rate, and some
patients gave birth to full-term babies; therefore, there is no statistical proof that the LTUAL
has any side effect on fertility.
Moreover, the reduced adhesion formation following laparoscopy is another benefit for
fertility of these patients. For laparotomy, the postoperative rate of adhesions, which are the
most probable risk for infertility, is high (80%) [24]. It has been hypothesized that laparoscopic
surgery, by maintaining hemostasis and minimizing peritoneal trauma and inflammation [25],
may result in reduced adhesion formation following abdominal and pelvic surgery [26-29].
This lack of adhesions could theoretically help to diminish the risk of infertility. Therefore, we
consider LTUAL to be a promising method in patients who wish to preserve fertility.
5. Conclusion
LTUAL preceded by LM provides several benefits to patients and is more in accordance with
the modern medical opinion regarding the preservation of the uterus and with limited side
effects on ovarian function and fertility. In addition, the procedure is preferable in patients
who wish to undergo future pregnancies. However, LTUAL plus LM cannot decrease the
recurrence rate of myomas. It must be emphasized that this study was limited by the lack of
randomization, and on the basis of this a more rigorous and detailed study should be under‐
taken. We strongly suggest that a randomized controlled trial is a next step for further
verification and discussion.
Nomenclature
LM; laparoscopic myomectomy
LUAO; laparoscopic uterine artery occlusion
LTUAL; laparoscopic transient uterine artery ligation
MBV; menstrual blood volume
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